#insilico — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #insilico, aggregated by home.social.
-
https://www.europesays.com/ie/672316/ AI hunts new uses for Phase 3 metabolic drug #AI #AiDrugDiscovery #DrugDevelopment #DrugDiscovery #Éire #Health #HealthCare #Healthcare #IE #Insilico #Ireland #SouthKorea #THPharm
-
Trending tickers: Exxon Mobil, Eli Lilly, Rio Tinto and Boohoo
Stocks had a mixed start to trading on Monday morning, amid intensified conflict in the Middle East, which…
#EuropeSays #Britain #Europe #EU #RioTinto #0.4% #ai #boohoogroup #Boohoo/DebenhamsGroup #DebenhamsGroup #EBITDA #ELILILLY #ExxonMobil #f #ftse #Insilico #InsilicoMedicine #Iran #MiddleEast #Monday #Mondaymorning #morning #nearly1% #nearly4% #Pilbara #RioTinto #Streeter #XOM
https://www.europesays.com/britain/116499/ -
https://www.europesays.com/britain/116499/ Trending tickers: Exxon Mobil, Eli Lilly, Rio Tinto and Boohoo #04% #ai #BoohooGroup #Boohoo/DebenhamsGroup #DebenhamsGroup #EBITDA #ELILILLY #ExxonMobil #f #ftse #Insilico #InsilicoMedicine #Iran #MiddleEast #Monday #MondayMorning #morning #Nearly1% #Nearly4% #Pilbara #RioTinto #Streeter #XOM
-
https://www.europesays.com/at/319280/ Leigh-Syndrom: KI- und Hirnorganoid-Studie setzt auf Sildenafil #AI #Alphafold2 #AntisenseOligonukleotid #ARTIFICIALINTELLIGENCE #AT #Austria #Autismus #DrugRepurposing #Epilepsie #Gesundheit #Health #Hirnorganoid #InSilico #KI #KünstlicheIntelligenz #LeighSyndrom #Neuroplastin #Österreich #Patientenansatz #PhaseIii #Proteinfaltung #Sildenafil #Splicing #WirkstoffRepositionierung #WirkstoffScreeing
-
K-Bio Courts Big Pharma With AI; Celltrion Books 150 Meetings
“After Cenobamate, our epilepsy treatment, was commercialized, one of the answers we reached after agonizing over how to…
#EuropeSays #Korea #KR #SamsungBiologics #AIdrugdevelopment #AstraZeneca #BIOUSA2026 #Celltrion #Galux #Insilico #Samsung #SKBiopharmaceuticals
https://www.europesays.com/korea/62825/ -
K-Bio Courts Big Pharma With AI; Celltrion Books 150 Meetings
“After Cenobamate, our epilepsy treatment, was commercialized, one of the answers we reached after agonizing over how to…
#EuropeSays #Korea #KR #SamsungBiologics #AIdrugdevelopment #AstraZeneca #BIOUSA2026 #Celltrion #Galux #Insilico #Samsung #SKBiopharmaceuticals
https://www.europesays.com/korea/62229/ -
Insilico Medicine has signed a global licensing deal worth up to 2.75 billion USD with Eli Lilly for an AI-discovered oral GLP-1 drug. The Hong Kong-listed AI drug discovery company received 115 million USD upfront and reported 2025 revenue of 56.2 million USD, with its drug discovery segment growing 693.6% year-over-year. https://pandaily.com/insilico-medicine-signs-2-75-b-deal-with-eli-lilly #China #Tech #AI #Insilico
-
Insilico Medicine has signed a global licensing deal worth up to 2.75 billion USD with Eli Lilly for an AI-discovered oral GLP-1 drug. The Hong Kong-listed AI drug discovery company received 115 million USD upfront and reported 2025 revenue of 56.2 million USD, with its drug discovery segment growing 693.6% year-over-year. https://pandaily.com/insilico-medicine-signs-2-75-b-deal-with-eli-lilly #China #Tech #AI #Insilico
-
Insilico Medicine has signed a global licensing deal worth up to 2.75 billion USD with Eli Lilly for an AI-discovered oral GLP-1 drug. The Hong Kong-listed AI drug discovery company received 115 million USD upfront and reported 2025 revenue of 56.2 million USD, with its drug discovery segment growing 693.6% year-over-year. https://pandaily.com/insilico-medicine-signs-2-75-b-deal-with-eli-lilly #China #Tech #AI #Insilico
-
Insilico Medicine has signed a global licensing deal worth up to 2.75 billion USD with Eli Lilly for an AI-discovered oral GLP-1 drug. The Hong Kong-listed AI drug discovery company received 115 million USD upfront and reported 2025 revenue of 56.2 million USD, with its drug discovery segment growing 693.6% year-over-year. https://pandaily.com/insilico-medicine-signs-2-75-b-deal-with-eli-lilly #China #Tech #AI #Insilico
-
Insilico Medicine has signed a global licensing deal worth up to 2.75 billion USD with Eli Lilly for an AI-discovered oral GLP-1 drug. The Hong Kong-listed AI drug discovery company received 115 million USD upfront and reported 2025 revenue of 56.2 million USD, with its drug discovery segment growing 693.6% year-over-year. https://pandaily.com/insilico-medicine-signs-2-75-b-deal-with-eli-lilly #China #Tech #AI #Insilico
-
https://www.europesays.com/uk/861822/ Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact #DrugDiscoveryAndDevelopment #EliLilly #Health #Insilico #InsilicoMedicine #Medication #OralDrugDiscoveryAndDevelopment #PharmaceuticalTechnology #UK #UnitedKingdom
-
https://www.europesays.com/ie/412470/ Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact #DrugDiscoveryAndDevelopment #Éire #EliLilly #Health #IE #Insilico #InsilicoMedicine #Ireland #Medication #OralDrugDiscoveryAndDevelopment #PharmaceuticalTechnology
-
#EliLilly and #Insilico Medicine have signed a $2.75 billion deal to bring #AIdeveloped #drugs to the global market. The agreement includes upfront payments, milestone payments, and royalties, and builds on their existing collaboration. https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html?eicker.news #tech #media #news
-
#EliLilly and #Insilico Medicine have signed a $2.75 billion deal to bring #AIdeveloped #drugs to the global market. The agreement includes upfront payments, milestone payments, and royalties, and builds on their existing collaboration. https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html?eicker.news #tech #media #news
-
#EliLilly and #Insilico Medicine have signed a $2.75 billion deal to bring #AIdeveloped #drugs to the global market. The agreement includes upfront payments, milestone payments, and royalties, and builds on their existing collaboration. https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html?eicker.news #tech #media #news
-
#EliLilly and #Insilico Medicine have signed a $2.75 billion deal to bring #AIdeveloped #drugs to the global market. The agreement includes upfront payments, milestone payments, and royalties, and builds on their existing collaboration. https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html?eicker.news #tech #media #news
-
#EliLilly and #Insilico Medicine have signed a $2.75 billion deal to bring #AIdeveloped #drugs to the global market. The agreement includes upfront payments, milestone payments, and royalties, and builds on their existing collaboration. https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html?eicker.news #tech #media #news
-
https://www.europesays.com/ie/259519/ Eli Lilly-backed Insilico eyes beyond pharma with new AI models #AI #ArtificialIntelligence #ArtificialIntelligence #Éire #Eli #eyes #IE #Insilico #Ireland #LillyBacked #Models #New #pharma #Technology
-
Il y a des projets auxquels j'ai participé et / ou donné mon avis professionnel qui ne décollent pas, et dont la dénomination se diffuse dans le "domaine public" : les clients potentiels ont des attentes non-dites...
#BioInformatique #InVivo #InVitro #InSilico #JumeauNumérique
-
Efforts to reduce animal experiments are important and should be pursued. But despite progress in #AI, #organoids, and #InSilico models, I’m not convinced we’re there yet — especially in #neuroscience, where #complexity and systemic #context matter. However, I do think we should stay committed and aim for reduction by all available means. I recently came across this article, which gives a good overview of the current state of the field:
-
Efforts to reduce animal experiments are important and should be pursued. But despite progress in #AI, #organoids, and #InSilico models, I’m not convinced we’re there yet — especially in #neuroscience, where #complexity and systemic #context matter. However, I do think we should stay committed and aim for reduction by all available means. I recently came across this article, which gives a good overview of the current state of the field:
-
Efforts to reduce animal experiments are important and should be pursued. But despite progress in #AI, #organoids, and #InSilico models, I’m not convinced we’re there yet — especially in #neuroscience, where #complexity and systemic #context matter. However, I do think we should stay committed and aim for reduction by all available means. I recently came across this article, which gives a good overview of the current state of the field:
-
Efforts to reduce animal experiments are important and should be pursued. But despite progress in #AI, #organoids, and #InSilico models, I’m not convinced we’re there yet — especially in #neuroscience, where #complexity and systemic #context matter. However, I do think we should stay committed and aim for reduction by all available means. I recently came across this article, which gives a good overview of the current state of the field:
-
Quantum Computing Can Help Unlock Understanding of Aging And Disease https://thequantuminsider.com/?p=2360517 #Research #aging #disease #Foxconn #Insilico #Insilico_Medicine #longevity #Quantum_Life #university_of_toronto #quantumdaily Insider Brief Researchers demonstrate how quantum computing can be integrated into the study of living organisms. The team believes it could provide greater insight into biological processes like aging and disease. Insilico, University of Toronto’s Acceleration C
-
Quantum Computing Can Help Unlock Understanding of Aging And Disease https://thequantuminsider.com/?p=2360517 #Research #aging #disease #Foxconn #Insilico #Insilico_Medicine #longevity #Quantum_Life #university_of_toronto #quantumdaily Insider Brief Researchers demonstrate how quantum computing can be integrated into the study of living organisms. The team believes it could provide greater insight into biological processes like aging and disease. Insilico, University of Toronto’s Acceleration C
-
#Biotech startup starts testing #AI-designed drug in humans. Artificial intelligence is expected to change for good the way drugs are crafted. #insilico #artificialintelligence #healthcare #fda @insilico @FDA @morganstanley
https://www.news-cafe.eu/?go=news&n=12870 -
#introduction Associate Prof in #medical #computational engineering at University of Leeds, interest in #musculoskeletal #biomechanics and using combined #invitro and #insilico methods to understand how everyone's joint is different, and how to use that knowledge in developing and testing repair devices.
-
#introduction Associate Prof in #medical #computational engineering at University of Leeds, interest in #musculoskeletal #biomechanics and using combined #invitro and #insilico methods to understand how everyone's joint is different, and how to use that knowledge in developing and testing repair devices.
-
#introduction Associate Prof in #medical #computational engineering at University of Leeds, interest in #musculoskeletal #biomechanics and using combined #invitro and #insilico methods to understand how everyone's joint is different, and how to use that knowledge in developing and testing repair devices.
-
@academicchatter @academicsunite Dear all. Anybody working with the #computational side of #environmental #biotechnology ? We try to devise #bioinformatics approach to investigates human coagulation factor II that is responsible for blod clotting as a possible method for water treatment against gram negative #bacteria (GNB). We tap in into the possibilities whether factor II could hydrolyse GNB in this #insilico implementations. You can check the paper in here: https://zenodo.org/record/5219013#.Y3Lo7uxBxQJ 🙂
-
@academicchatter @academicsunite Dear all. Anybody working with the #computational side of #environmental #biotechnology ? We try to devise #bioinformatics approach to investigates human coagulation factor II that is responsible for blod clotting as a possible method for water treatment against gram negative #bacteria (GNB). We tap in into the possibilities whether factor II could hydrolyse GNB in this #insilico implementations. You can check the paper in here: https://zenodo.org/record/5219013#.Y3Lo7uxBxQJ 🙂
-
@academicchatter @academicsunite Dear all. Anybody working with the #computational side of #environmental #biotechnology ? We try to devise #bioinformatics approach to investigates human coagulation factor II that is responsible for blod clotting as a possible method for water treatment against gram negative #bacteria (GNB). We tap in into the possibilities whether factor II could hydrolyse GNB in this #insilico implementations. You can check the paper in here: https://zenodo.org/record/5219013#.Y3Lo7uxBxQJ 🙂
-
@academicchatter @academicsunite Dear all. Anybody working with the #computational side of #environmental #biotechnology ? We try to devise #bioinformatics approach to investigates human coagulation factor II that is responsible for blod clotting as a possible method for water treatment against gram negative #bacteria (GNB). We tap in into the possibilities whether factor II could hydrolyse GNB in this #insilico implementations. You can check the paper in here: https://zenodo.org/record/5219013#.Y3Lo7uxBxQJ 🙂
-
@academicchatter @academicsunite Dear all. Anybody working with the #computational side of #environmental #biotechnology ? We try to devise #bioinformatics approach to investigates human coagulation factor II that is responsible for blod clotting as a possible method for water treatment against gram negative #bacteria (GNB). We tap in into the possibilities whether factor II could hydrolyse GNB in this #insilico implementations. You can check the paper in here: https://zenodo.org/record/5219013#.Y3Lo7uxBxQJ 🙂